451 related articles for article (PubMed ID: 17156600)
1. [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)].
Mehnert A; Herschbach P; Berg P; Henrich G; Koch U
Z Psychosom Med Psychother; 2006; 52(3):274-88. PubMed ID: 17156600
[TBL] [Abstract][Full Text] [Related]
2. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors.
Mehnert A; Berg P; Henrich G; Herschbach P
Psychooncology; 2009 Dec; 18(12):1273-80. PubMed ID: 19267364
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
[TBL] [Abstract][Full Text] [Related]
4. Fear of progression in partners of chronically ill patients.
Zimmermann T; Herschbach P; Wessarges M; Heinrichs N
Behav Med; 2011 Jul; 37(3):95-104. PubMed ID: 21895427
[TBL] [Abstract][Full Text] [Related]
5. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study.
van den Beuken-van Everdingen MH; Peters ML; de Rijke JM; Schouten HC; van Kleef M; Patijn J
Psychooncology; 2008 Nov; 17(11):1137-45. PubMed ID: 18484568
[TBL] [Abstract][Full Text] [Related]
6. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
7. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
8. [Fear of progression in parents of children with cancer: adaptation of the Fear of Progression Questionnaire and correlates].
Schepper F; Abel K; Herschbach P; Christiansen H; Mehnert A; Martini J
Klin Padiatr; 2015 May; 227(3):151-6. PubMed ID: 25811743
[TBL] [Abstract][Full Text] [Related]
9. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
10. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Portuguese Version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) in Portuguese Cancer Survivors.
Silva S; Bártolo A; Santos IM; Paiva D; Monteiro S
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36553990
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing fear of cancer recurrence in patients with breast cancer: Evidence from a survey in Yancheng, China.
Niu L; Liang Y; Niu M
J Obstet Gynaecol Res; 2019 Jul; 45(7):1319-1327. PubMed ID: 31016820
[TBL] [Abstract][Full Text] [Related]
13. Increased fear of progression in cancer patients with recurrence.
Shim EJ; Shin YW; Oh DY; Hahm BJ
Gen Hosp Psychiatry; 2010; 32(2):169-75. PubMed ID: 20302991
[TBL] [Abstract][Full Text] [Related]
14. Fear of cancer recurrence and its predictors among cervical cancer survivors.
Hanprasertpong J; Geater A; Jiamset I; Padungkul L; Hirunkajonpan P; Songhong N
J Gynecol Oncol; 2017 Nov; 28(6):e72. PubMed ID: 28758378
[TBL] [Abstract][Full Text] [Related]
15. Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis.
Kwakkenbos L; van den Hoogen FH; Custers J; Prins J; Vonk MC; van Lankveld WG; Becker ES; van den Ende CH
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):930-4. PubMed ID: 22262505
[TBL] [Abstract][Full Text] [Related]
16. Does depression decrease the moderating effect of self-efficacy in the relationship between illness perception and fear of progression in breast cancer?
Shim EJ; Lee JW; Min YH
Psychooncology; 2018 Feb; 27(2):539-547. PubMed ID: 28816370
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.
Lengacher CA; Johnson-Mallard V; Post-White J; Moscoso MS; Jacobsen PB; Klein TW; Widen RH; Fitzgerald SG; Shelton MM; Barta M; Goodman M; Cox CE; Kip KE
Psychooncology; 2009 Dec; 18(12):1261-72. PubMed ID: 19235193
[TBL] [Abstract][Full Text] [Related]
18. Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population.
Blanchin M; Dauchy S; Cano A; Brédart A; Aaronson NK; Hardouin JB
Health Qual Life Outcomes; 2015 Jul; 13():110. PubMed ID: 26220672
[TBL] [Abstract][Full Text] [Related]
19. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Slovenian version of Hospital Anxiety and Depression Scale in female cancer patients.
Miklavcic IV; Snoj Z; Mlakar J; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):148-52. PubMed ID: 18587282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
